Sort
172,184 grants matching “inflammation”
Defining the role of BPA in promoting obesity and associated metabolic complicati
$814,214Beverly S Rubin · Tufts University Boston · RC2 · FY2010 · ES
Vascular contributions to HIV-associated Neurocognitive Disorders (HAND)
$814,209Jose Gutierrez · Columbia University Health Sciences · R01 · FY2023 · AG
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV
$814,084Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2021 · HL
Protection against early SIV brain injury with adjunctive therapy to cART
$814,050Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2023 · NS
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
$814,022Lishan Su · University Of Maryland Baltimore · R01 · FY2022 · AI
Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)
$813,868Russell Ryan Kempker · Emory University · R01 · FY2023 · AI
Immune Dysfunction in HIV+ Opioid Users
$813,855Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2021 · DA
Dynamic control of vascular permeability in development and disease
$813,824Anne Christine Eichmann · Yale University · R01 · FY2022 · HL
Pathways underlying kidney vulnerability in outdoor workers
$813,809Zachary Joseph Schlader · Trustees Of Indiana University · R01 · FY2025 · DK
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2017 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2016 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2020 · DA
RNA-mediated endotheliopathy in diabetic vasculopathy
$813,786Zhen Bouman Chen · Beckman Research Institute/City Of Hope · R35 · FY2025 · HL
Immune interventions in SIV-infected ART-suppressed infant macaques
$813,748Ann M Chahroudi · Emory University · R01 · FY2020 · AI
Precursors of Stroke Incidence and Prognosis
$813,711Philip A Wolf · Boston University Medical Campus · R01 · FY2009 · NS
Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic
$813,686Yolanda Renee Lea-Currie · Zen-Bio, Inc. · R44 · FY2019 · AG
Core A: Animal Models
$813,635David A Stoltz · University Of Iowa · P01 · FY2015 · HL
Role of Macrophages in Lung Disease Pathogenesis of Pediatric AIDS
$813,621Marcelo J Kuroda · Tulane University Of Louisiana · R01 · FY2015 · HL
A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimer's Disease Clinical Trials
$813,603Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2019 · AG
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$813,598Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
Azithromycin Reduction to Reach Elimination of Trachoma
$813,579Catherine Elizabeth Oldenburg · University Of California, San Francisco · UG1 · FY2020 · EY
Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma
$813,544Swey-Shen Chen · Ige Therapeutics, Inc. · R44 · FY2018 · AI
Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma
$813,544Swey-Shen Chen · Ige Therapeutics, Inc. · R44 · FY2017 · AI
Preclinical development of an immunomodulatory agent capable of mitigating influenza related hypercytokinemia
$813,514Jodi K Craigo · Cytoagents, Inc. · R44 · FY2021 · AI
Peripheral Markers of Phenotypic Heterogeneity in COPD
$813,487Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · HL